Skip to main content

HB 920 — Louisiana

INSURANCE/HEALTH: Requires drug manufacturers to limit pricing of GLP-1 medications for health insurance plans (OR INCREASE GF EX See Note)

Introduced 2026 session House

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • HB 920 is a bill in the Louisiana House, 2026 session, introduced February 27, 2026.
  • Sponsored by Edmond Jordan.
  • Current status: introduced.
  • Most recent action (March 9, 2026): Read by title, under the rules, referred to the Committee on Insurance.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Edmond Jordan

History

  1. Introduced, completed
  2. Passed House, in progress
  3. Passed Senate, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. House First appeared in the Interim Calendar on 2/27/2026.
  2. House Under the rules, provisionally referred to the Committee on Insurance.
  3. House Prefiled.
  4. House Read by title, under the rules, referred to the Committee on Insurance. Latest

Source: Open States. Last checked November 3, 2026. How we keep this accurate ›